Last edition
News about
Eris Lifesciences Secures ANVISA Approval for its Manufacturing Unit in Ahmedabad
Eris Lifesciences has received ANVISA approval for a manufacturing unit at its Ahmedabad campus, paving the way for entry into Brazil, South America’s largest pharmaceutical market.
Harbour BioMed Names Yajie Li as Chief Medical Officer
As Chief Medical Officer (CMO), Yajie Li will be based in Shanghai and report directly to Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed.
Bio-Thera, STADA Expand Biosimilars Alliance to Include Tocilizumab
Bio-Thera Solutions and STADA Arzneimittel have extended their biosimilars alliance to include tocilizumab, with Bio-Thera handling development and supply while STADA secures exclusive commercialization rights across Europe and select markets.
Snapdragon Chemistry Expands Massachusetts Facility to Support Peptide Projects
Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts, by adding a new GMP manufacturing suite to strengthen the development and manufacturing of peptide therapies.
Collaboration is Key to Resilient Medical Device Ecosystem: Pharma Secretary
Amit Agrawal, Secretary of the Department of Pharmaceuticals, has emphasised the need to strengthen the medical device sector ecosystem not only through technology and skilled manpower, but also by establishing “internationally accredited laboratories, adopting globally harmonised standards and supporting clinical investigations for innovative devices.”
Akums to Set Up Manufacturing Facility in Zambia
Akums Drugs and Pharmaceuticals has signed a framework agreement with the Government of the Republic of Zambia to establish a local manufacturing facility in the country and supply essential medicines.
Collaboration Aims to Scale AAV Manufacturing for Rare Neuromuscular Junction Diseases
NMJ disorders often cause severe muscle weakness, with many patients requiring respiratory support, wheelchairs, or tube feeding. These genetic diseases can be life-threatening, often diagnosed in childhood but sometimes appearing later in life.
Vyome and Embryyo Sign MoU to Advance AI-Enabled Medical Devices
US-based Vyome Holdings has signed an MoU with Embryyo Technologies, India’s leading medical device innovation studio, to jointly explore opportunities in the multi-billion-dollar AI-enabled medical device market.
Gyre Therapeutics Appoints Dan Weng to Board of Directors
Gyre Therapeutics, a US-based commercial-stage biopharmaceutical company focused on innovative therapies for organ fibrosis, has announced the appointment of Dr. Dan Weng, former CEO of Medelis, to its Board of Directors.
Finetech Launches New Series of Tablet Counting Machines
Finetech Pharma has unveiled its new series of multifunctional tablet counting machines, incorporating the latest automation technology to reduce packaging errors and improve efficiency.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy